Alfa Laval signs joint marketing agreement with Millipore

Alfa Laval signs joint marketing agreement with Millipore Alfa Laval, a world leader in centrifugal separation, heat transfer and fluid handling, and Millipore Corporation, a multinational bioscience company, today announced a USA joint marketing agreement for Alfa Laval's high-speed biotechnology centrifuges and Millipore's multi-layer Millistak+® HC depth filters. This integration of equipment will allow the efficient recovery of biopharmaceutical proteins generated by cell culture and fermentation. "The first steps in drug recovery after a bioreactor are often the most challenging and require a series of centrifugation and filtration steps. By combining our knowledge with Millipore's we are able to offer our customers with an optimal solution for primary recovery," says Kirk Spitzer, President of Alfa Laval Inc. the U.S. subsidiary of the Alfa Laval Group. Under the terms of the agreement, each company will exclusively promote the other company's products to customers requiring centrifugation and depth filtration. Furthermore, this partnership encompasses assistance with sales activities, preparation and publication of technical articles, joint field- testing and customer demonstrations of this centrifugation and depth filtration combination. "The expertise from both companies will speed the drug development process and enhance customer process economics. Integrating and optimizing the key technologies of centrifugal separation and depth filtration will improve customers' process efficiency, lower capital costs and reduce operating costs," says Susan Vogt, President of Millipore's Biopharmaceutical Division. Editor's notes: Alfa Laval is a leading global provider of specialized products and engineering solutions based on its key technologies of heat transfer, separation and fluid handling. The company's equipment, systems and services are dedicated to assisting customers in optimizing the performance of their processes. The solutions help them to heat, cool, separate and transport products in industries that produce foods and beverages, chemicals and petrochemicals, pharmaceuticals, starch, sugar and ethanol. Alfa Laval's products are also used in power plants, aboard ships, in the mechanical engineering industry, in the mining industry and for wastewater treatment, as well as for comfort climate and refrigeration applications. Alfa Laval's worldwide organization works closely with customers in nearly 100 countries to help them stay ahead in the global arena. Alfa Laval is listed on the Stockholm Exchange and, in 2002, posted annual sales of about SEK 15 billion (approx. 1.7 billion euros). The company has some 9,100 employees. For further information, please visit the Alfa Laval website at www.alfalaval.com Millipore is a multinational bioscience company that provides technologies, tools and service for the discovery, development and production of new therapeutic drugs. It serves the life science, biotechnology and pharmaceutical industries. Millipore is listed on the New York Stock Exchange For more information, please visit the Millipore website at www.millipore.com. For further information please contact: Peter Torstensson Mikael Sjöblom Vice President, Communications Investor Relation Manager Mobile: +46 709 33 72 31 Mobile: +46 709 78 74 82 peter.torstensson@alfalaval.com mikael.sjoblom@alfalaval.com ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/07/28/20030728BIT00290/wkr0001.doc http://www.waymaker.net/bitonline/2003/07/28/20030728BIT00290/wkr0002.pdf